GACP cultivation under Swissmedic, every batch documented from clone to hand-over.
Grown with the precision of a laboratory.
Studio Verde is building a data-driven indoor facility for medical cannabis in Switzerland: four flower rooms and an in-house GMP zone on 1'015 m². We know the process, and we build it phase by phase.
Camera-guided plant scanning is where we are heading. Our first harvests run on proven, standard indoor cultivation; automation is introduced step by step, starting in the experimental room.
- Facility floor
- 1'015 m²
- Flower rooms
- 4
- Canopy at full build
- ~240 m²
- First harvest
- 05/2027
Medical cannabis Europe can rely on.
Two flower rooms in 2027, four in 2028, then an in-house GMP zone. Capital follows proven output.
Own genetics, fixed 62-day cycles and sensor-driven climate give the same quality every run.
Every room has a purpose.
Explore the floor plan in 3D. Switch between the three build phases, show the supply and exhaust air system and tap any room for details.
Model based on the current floor plan (April 2026); dimensions are approximate.
Secure your allocation of our first harvests.
Who we are looking for
- Pharmaceutical manufacturers & processors
- Medical cannabis distributors & wholesalers
- EU importers
- Extract & formulation producers
Planned output, not guaranteed. Offtake starts with a non-binding letter of intent. Swissmedic requires a written offtake agreement for the entire harvest of each cultivation permit, with a buyer licensed to handle controlled substances (BetmG).
Invest in a new standard.
A licensed, capital-efficient entry into Europe's regulated medical cannabis market, built in Switzerland in three clear phases.
Figures are planning estimates from the business plan (Oct 2026), before depreciation and tax. This is not an offer of securities.
Let's talk.
Tell us who you are and what you are looking for.
We reply within two working days.
Or write directly: contact@studioverde.ch